DRESS syndrome after KRd (carfilzomib, lenalidomide, dexamethasone) therapy in a patient with multiple myeloma

Pol Arch Intern Med. 2021 Oct 27;131(10):16056. doi: 10.20452/pamw.16056. Epub 2021 Jul 5.

Authors

Małgorzata Gajewska¹, Agnieszka Terlikowska-Brzósko², Waldemar Sawicki¹, Katarzyna Wróbel³, Małgorzata Lorent⁴, Piotr Rzepecki¹

Affiliations

¹ Department of Hematology, Military Institute of Medicine, Warsaw, Poland
² Department of Dermatology, Military Institute of Medicine, Warsaw, Poland. aterlikowska-brzosko@wim.mil.pl
³ Department of Dermatology, Military Institute of Medicine, Warsaw, Poland
⁴ Department of Pathomorphology, Military Institute of Medicine, Warsaw, Poland

PMID: 34223746
DOI: 10.20452/pamw.16056

No abstract available

MeSH terms

Dexamethasone / adverse effects
Drug Hypersensitivity Syndrome*
Humans
Lenalidomide / adverse effects
Multiple Myeloma* / drug therapy
Neoplasm Recurrence, Local
Oligopeptides

Substances

Oligopeptides
carfilzomib
Dexamethasone
Lenalidomide